The antitumour activity of the prodrug N-L-leucyldoxorubicin and its parent compound doxorubicin in human tumour xenografts.

Breistol K, Hendriks HR, Berger DP, Langdon SP, Fiebig HH and Fodstad O

Research output: Contribution to journal › Article › peer-review

Cite this

@article{40dd9887de9b4a4da9c59c542c04138b,

title = "The antitumour activity of the prodrug N-L-leucyldoxorubicin and its parent compound doxorubicin in human tumour xenografts.",

author = "{Breistol K, Hendriks HR, Berger DP, Langdon SP, Fiebig HH and Fodstad O} and Simon Langdon",

year = "1998",

language = "English",

volume = "34",

pages = "1602--1606",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon Press",

}

TY - JOUR

T1 - The antitumour activity of the prodrug N-L-leucyldoxorubicin and its parent compound doxorubicin in human tumour xenografts.

AU - Breistol K, Hendriks HR, Berger DP, Langdon SP, Fiebig HH and Fodstad O

AU - Langdon, Simon

PY - 1998

Y1 - 1998

M3 - Article

SN - 0959-8049

VL - 34

SP - 1602

EP - 1606

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -